LPL Financial’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5K | Buy |
59,390
+16,465
| +38% | +$11.2K | ﹤0.01% | 5232 |
|
|
2025
Q1 | $39.1K | Sell |
42,925
-4
| -0% | -$4 | ﹤0.01% | 5045 |
|
|
2024
Q4 | $46.8K | Buy |
42,929
+25,004
| +139% | +$27.3K | ﹤0.01% | 4986 |
|
|
2024
Q3 | $13.6K | Hold |
17,925
| – | – | ﹤0.01% | 5005 |
|
|
2024
Q2 | $22.2K | Buy |
17,925
+5,000
| +39% | +$6.2K | ﹤0.01% | 4825 |
|
|
2024
Q1 | $24.4K | Hold |
12,925
| – | – | ﹤0.01% | 4753 |
|
|
2023
Q4 | $34.1K | Buy |
12,925
+2,355
| +22% | +$6.22K | ﹤0.01% | 4629 |
|
|
2023
Q3 | $24.3K | Hold |
10,570
| – | – | ﹤0.01% | 4538 |
|
|
2023
Q2 | $38.6K | Hold |
10,570
| – | – | ﹤0.01% | 4402 |
|
|
2023
Q1 | $37.7K | Hold |
10,570
| – | – | ﹤0.01% | 4317 |
|
|
2022
Q4 | $30.1K | Hold |
10,570
| – | – | ﹤0.01% | 4302 |
|
|
2022
Q3 | $24K | Buy |
+10,570
| New | +$24K | ﹤0.01% | 4270 |
|